WEST PHARMACEUTICAL SERVICES, INC. (WST) Return on equity 2016–2025
WEST PHARMACEUTICAL SERVICES, INC. (WST) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
15.5%FY2025 · since FY2016: 12.9% → 15.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 15.5% | -2.8 pp |
| FY2024 | 18.4% | -2.2 pp |
| FY2023 | 20.6% | -1.2 pp |
| FY2022 | 21.8% | -6.5 pp |
| FY2021 | 28.3% | +9.7 pp |
| FY2020 | 18.7% | +3.3 pp |
| FY2019 | 15.4% | +0.5 pp |
| FY2018 | 14.8% | +3.0 pp |
| FY2017 | 11.8% | -1.1 pp |
| FY2016 | 12.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice